Related references
Note: Only part of the references are listed.Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution
Xiao Liu et al.
GASTROENTEROLOGY (2020)
IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease
Hsiao-Yen Ma et al.
JOURNAL OF HEPATOLOGY (2020)
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya F. Gulamhusein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat
Ana C. Maretti-Mira et al.
HEPATOLOGY (2019)
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
Tatsuo Kanda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Inflammatory pathways in alcoholic steatohepatitis
Bin Gao et al.
JOURNAL OF HEPATOLOGY (2019)
Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics
Amy G. Feldman et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice
Takahiro Nishio et al.
JOURNAL OF HEPATOLOGY (2019)
Inhibition of Human Neutrophil Extracellular Trap (NET) Production by Propofol and Lipid Emulsion
Angela Meier et al.
FRONTIERS IN PHARMACOLOGY (2019)
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Vlad Ratziu et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
Mitchell Shiffman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation
Nadine Gehrke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
Cholsoon Jang et al.
CELL METABOLISM (2018)
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
Kuo Du et al.
GASTROENTEROLOGY (2018)
Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis
Thoetchai (Bee) Peeraphatdit et al.
JOURNAL OF HEPATOLOGY (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity
Shishir Shetty et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
Ju Youn Kim et al.
CELL (2018)
Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis
Igor Maricic et al.
JOURNAL OF IMMUNOLOGY (2018)
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Changyu Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
Rolf Teschke
BIOMEDICINES (2018)
Neutrophils Alleviate Fibrosis in the CCl4-Induced Mouse Chronic Liver Injury Model
Eiko Saijou et al.
HEPATOLOGY COMMUNICATIONS (2018)
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
Katharina Brandl et al.
JOURNAL OF HEPATOLOGY (2018)
The Hepatic Matrisome Responds Dynamically to Injury: Characterization of Transitional Changes to the Extracellular Matrix in Mice
Veronica L. Massey et al.
HEPATOLOGY (2017)
The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis
Panagiotis Flevaris et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
Naoki Ikenaga et al.
GUT (2017)
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha et al.
JOURNAL OF HEPATOLOGY (2017)
Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)
Martin W. Rowbottom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shabnam Shalapour et al.
NATURE (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis
Feliciano Chanana Paquissi
FRONTIERS IN IMMUNOLOGY (2017)
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
Tejas R. Karhadkar et al.
SCIENTIFIC REPORTS (2017)
Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
Phase I and Preliminary Phase II Study ofTRC105in Combination with Sorafenib in Hepatocellular Carcinoma
Austin G. Duffy et al.
CLINICAL CANCER RESEARCH (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation (vol 26, pg 394, 2017)
Chai-Wan Kim et al.
CELL METABOLISM (2017)
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases
Junichiro Sonoda et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2017)
Liver macrophages in tissue homeostasis and disease
Oliver Krenkel et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Integrin alpha v beta 6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis
Zhen-Wei Peng et al.
HEPATOLOGY (2016)
Microbiota and Alcoholic Liver Disease
Peng Chen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer
Angeles Duran et al.
CANCER CELL (2016)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
Pathogenesis of nonalcoholic steatohepatitis
Wensheng Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection
Mei Lu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
The vitamin D receptor agonist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: An experimental study
Eman Wahsh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice
Susan B. Liu et al.
FASEB JOURNAL (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
Mei Xiang et al.
JOURNAL OF HEPATOLOGY (2016)
TGF-/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Fengyun Xu et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)
Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
Maria Lina Tornesello et al.
ONCOTARGET (2016)
Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease
E. C. Verna et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Methylsulfonylmethane inhibits NLRP3 inflammasome activation
Huijeong Ahn et al.
CYTOKINE (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Guillaume Lassailly et al.
GASTROENTEROLOGY (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic
Chris J. Weston et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer
Nasun Hah et al.
21ST CENTURY GENETICS: GENES AT WORK, VOL 80, 2015 (2015)
Mesodermal Mesenchymal Cells Give Rise to Myofibroblasts, but Not Epithelial Cells, in Mouse Liver Injury
Ingrid Lua et al.
HEPATOLOGY (2014)
Transcriptional Repression of the Transforming Growth Factor β (TGF-β) Pseudoreceptor BMP and Activin Membrane-bound Inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 Enhances TGF-β Signaling in Hepatic Stellate Cells
Cheng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hepatic stellate cells contribute to progenitor cells and liver regeneration
Claus Kordes et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse
Anna Moles et al.
JOURNAL OF HEPATOLOGY (2014)
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi-Sen Ding et al.
NATURE (2014)
Correction: Chylomicrons Promote Intestinal Absorption and Systemic Dissemination of Dietary Antigen (Ovalbumin) in Mice
Yuehui Wang et al.
PLoS One (2014)
Origin of myofibroblasts in the fibrotic liver in mice
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Inactivation of myofibroblasts during regression of liver fibrosis
Tatiana Kisseleva et al.
CELL CYCLE (2013)
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
John E. Eaton et al.
GASTROENTEROLOGY (2013)
Cross-Talk Between Notch and Hedgehog Regulates Hepatic Stellate Cell Fate in Mice
Guanhua Xie et al.
HEPATOLOGY (2013)
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice
Juan E. Puche et al.
HEPATOLOGY (2013)
Hepatoprotective and anti-fibrotic functions of interleukin-22: Therapeutic potential for the treatment of alcoholic liver disease
Xiaoni Kong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
Alexander Wehr et al.
JOURNAL OF IMMUNOLOGY (2013)
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
Neil C. Henderson et al.
NATURE MEDICINE (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Overexpression of Endoglin Modulates TGF-β1-Signalling Pathways in a Novel Immortalized Mouse Hepatic Stellate Cell Line
Steffen K. Meurer et al.
PLOS ONE (2013)
Non-alcoholic steatohepatitis: a microbiota-driven disease
Alexander R. Moschen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?
Ning Ding et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Bariatric Surgery as Potential Treatment for Nonalcoholic Fatty Liver Disease: A Future Treatment by Choice or by Chance?
Shuja Hafeez et al.
JOURNAL OF OBESITY (2013)
Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Guanhua Xie et al.
GASTROENTEROLOGY (2012)
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Juliane S. Troeger et al.
GASTROENTEROLOGY (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis
Antonella Pellicoro et al.
HEPATOLOGY (2012)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent
Tomonori Aoyama et al.
HEPATOLOGY (2012)
Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation
Maria Jesus Perugorria et al.
HEPATOLOGY (2012)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Genetic variants in candidate genes influencing NAFLD progression
Michelino Di Rosa et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
Ekihiro Seki et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
Ferdinando A. Giannone et al.
LABORATORY INVESTIGATION (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Tatiana Kisseleva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
Prakash Ramachandran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Migration of Fibrocytes in Fibrogenic Liver Injury
David Scholten et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Role of IL-17 and Th17 Cells in Liver Diseases
Linda Hammerich et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
Barham K. Abu Dayyeh et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Lysophosphatidic acid-1-receptor targeting agents for fibrosis
Chloe Rancoule et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
It Is a Good Morning Exercise for a Research Scientist to Discard a Pet Hypothesis Every Day Before Breakfast: It Keeps Him Young (Konrad Lorenz, 1903-1989)
John P. Iredale et al.
GASTROENTEROLOGY (2011)
Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice
Yury Popov et al.
GASTROENTEROLOGY (2011)
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Bin Gao et al.
GASTROENTEROLOGY (2011)
Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis
Johannes Kluwe et al.
GUT (2011)
Tumor-Secreted Lysophostatidic Acid Accelerates Hepatocellular Carcinoma Progression by Promoting Differentiation of Peritumoral Fibroblasts in Myofibroblasts
Antonio Mazzocca et al.
HEPATOLOGY (2011)
Lineage Tracing Demonstrates No Evidence of Cholangiocyte Epithelial-to-Mesenchymal Transition in Murine Models of Hepatic Fibrosis
Andrew S. Chu et al.
HEPATOLOGY (2011)
An Essential Role for Monocyte Chemoattractant Protein-1 in Alcoholic Liver Injury: Regulation of Proinflammatory Cytokines and Hepatic Steatosis in Mice
Pranoti Mandrekar et al.
HEPATOLOGY (2011)
The inflammasome: an integrated view
Olaf Gross et al.
IMMUNOLOGICAL REVIEWS (2011)
CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice
Sachiko Ishikawa et al.
JOURNAL OF HEPATOLOGY (2011)
The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysis
Suzanne E. Mahady et al.
JOURNAL OF HEPATOLOGY (2011)
IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β-Independent Smad Signaling
Yan Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection
Tatiana Kisseleva et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice
Jue Wei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis
Yury Popov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Genetic Labeling Does Not Detect Epithelial-to-Mesenchymal Transition of Cholangiocytes in Liver Fibrosis in Mice
David Scholten et al.
GASTROENTEROLOGY (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Jelena Mann et al.
GASTROENTEROLOGY (2010)
Portal Fibroblasts: Underappreciated Mediators of Biliary Fibrosis
Jonathan A. Dranoff et al.
HEPATOLOGY (2010)
Alcoholic Liver Disease
Robert S. O'Shea et al.
HEPATOLOGY (2010)
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role off Signal Transducer and Activator of Transcription 3
Sung Hwan Ki et al.
HEPATOLOGY (2010)
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Kojiro Taura et al.
HEPATOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Distinct proteomic features of two fibrogenic liver cell populations: Hepatic stellate cells and portal myofibroblasts
Nelly Bosselut et al.
PROTEOMICS (2010)
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Kate Schroder et al.
SCIENCE (2010)
Nuclear Receptor Regulation of the Adaptive Response of Bile Acid Transporters in Cholestasis
Martin Wagner et al.
SEMINARS IN LIVER DISEASE (2010)
The impact of the extracellular matrix on inflammation
Lydia Sorokin
NATURE REVIEWS IMMUNOLOGY (2010)
SENESCENCE Senescence in tumours: evidence from mice and humans
Manuel Collado et al.
NATURE REVIEWS CANCER (2010)
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Inflammasome-mediated regulation of hepatic stellate cells
Azuma Watanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Cholestasis and cholestatic syndromes
Gideon M. Hirschfield et al.
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial
Pedram Kharaziha et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Yiannis N. Kallis et al.
GASTROENTEROLOGY (2009)
Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis
Marlene Dominguez et al.
GASTROENTEROLOGY (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
p75 Neurotrophin Receptor Signaling Regulates Hepatic Myofibroblast Proliferation and Apoptosis in Recovery from Rodent Liver Fibrosis
Timothy J. Kendall et al.
HEPATOLOGY (2009)
The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease
Arnaud Lemmers et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
CCR2 Promotes Hepatic Fibrosis in Mice
Ekihiro Seki et al.
HEPATOLOGY (2009)
Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury
Jozsef Dudas et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Hyaluronan Orchestrates Transforming Growth Factor-β1-dependent Maintenance of Myofibroblast Phenotype
Jason Webber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
Songwen Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
Piero Vavassori et al.
JOURNAL OF IMMUNOLOGY (2009)
Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+regulatory T cells
Paul L. Bollyky et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis
Robert M. Strieter et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
Bin Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Molecular mechanisms involved in NAFLD progression
Mariano Malaguarnera et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly
M. R. Alison et al.
JOURNAL OF PATHOLOGY (2009)
MEDICAL PROGRESS Alcoholic Hepatitis
Michael R. Lucey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts
Darrell Pilling et al.
PLOS ONE (2009)
The Extracellular Matrix: Not Just Pretty Fibrils
Richard O. Hynes
SCIENCE (2009)
Isolation of Mesenchymal Stem Cells (MSCs) from Green Fluorescent Protein Positive (GFP(+)) Transgenic Rodents: The Grass Is Not Always Green(er)
Matthew T. Harting et al.
STEM CELLS AND DEVELOPMENT (2009)
Reversibility of liver fibrosis
Prakash Ramachandran et al.
ANNALS OF HEPATOLOGY (2009)
Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney
Shuei-Liong Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Mechanisms of fibrogenesis
Tatiana Kisseleva et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
Laurie D. DeLeve et al.
HEPATOLOGY (2008)
The role of matrix stiffness in regulating cell behavior
Rebecca G. Wells
HEPATOLOGY (2008)
Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells
Ping-Fang Hu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes
Xin Zhang et al.
JOURNAL OF IMMUNOLOGY (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Interleukin-22 but not interleukin-17 provides protection to Hepatocytes during acute liver inflammation
Lauren A. Zenewicz et al.
IMMUNITY (2007)
Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P
Darrell Pilling et al.
JOURNAL OF IMMUNOLOGY (2007)
Involvement of hyaluronan in regulation of fibroblast phenotype
Soma Meran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg et al.
NATURE MEDICINE (2007)
Cutting edge:: High molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells
Paul L. Bollyky et al.
JOURNAL OF IMMUNOLOGY (2007)
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid
Daniel Mucida et al.
SCIENCE (2007)
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis
Jonathan A. Fallowfield et al.
JOURNAL OF IMMUNOLOGY (2007)
The role of CXC chemokines in pulmonary fibrosis
Robert M. Strieter et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
John P. Iredale
JOURNAL OF CLINICAL INVESTIGATION (2007)
Fibrocytes in lung disease
Brigitte N. Gomperts et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Blockade of renin-angiotensin system in antifibrotic therapy
Hitoshi Yoshiji et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases
Hitoshi Yoshiji et al.
CURRENT MEDICINAL CHEMISTRY (2007)
STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity
Won-Il Jeong et al.
HEPATOLOGY (2006)
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain - Enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism
Errol S. Wijelath et al.
CIRCULATION RESEARCH (2006)
Hepatic stellate cells and the reversal of fibrosis
Tatiana Kisseleva et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
Tatiana Kisseleva et al.
JOURNAL OF HEPATOLOGY (2006)
Loss of MMP 13 attenuates murine hepatic injury and fibrosis during Cholestasis
Hiroshi Uchinami et al.
HEPATOLOGY (2006)
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans
E. Novo et al.
GUT (2006)
The bone marrow functionally contributes to liver fibrosis
Francesco P. Russo et al.
GASTROENTEROLOGY (2006)
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000
Benjamin L. Shneider et al.
JOURNAL OF PEDIATRICS (2006)
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners
S Radaeva et al.
GASTROENTEROLOGY (2006)
Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence
SS Thorgeirsson et al.
HEPATOLOGY (2006)
Adipokines in NASH:: Postprandial lipid metabolism as a link between adiponectin and liver disease
G Musso et al.
HEPATOLOGY (2005)
TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis
P Bonniaud et al.
JOURNAL OF IMMUNOLOGY (2005)
A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs
M Mohammadi et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2005)
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
L Yang et al.
JOURNAL OF HEPATOLOGY (2005)
Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex
FJ Blanco et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis
AC de Gouville et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis
RG Wells
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids
F Geissmann et al.
PLOS BIOLOGY (2005)
Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice
K Sudo et al.
CYTOKINE (2005)
Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells
S Rahman et al.
BMC CELL BIOLOGY (2005)
Adipogenic transcriptional regulation of hepatic stellate cells
HY She et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of inhibitor of kappa B kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis
F Oakley et al.
GASTROENTEROLOGY (2005)
Caspase inhibitors: A pharmaceutical industry perspective
SD Linton
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
JS Duffield et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow
L Song et al.
FASEB JOURNAL (2004)
Circulating fibrocytes: collagen-secreting cells of the peripheral blood
TE Quan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis
SJ Forbes et al.
GASTROENTEROLOGY (2004)
Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
AJ Czaja et al.
JOURNAL OF HEPATOLOGY (2004)
Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells
S Hazra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse
A Canbay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation
LD DeLeve et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
RJ Phillips et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Bone marrow-derived progenitor cells in pulmonary fibrosis
N Hashimoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats
CJ Parsons et al.
HEPATOLOGY (2004)
Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking
R Issa et al.
GASTROENTEROLOGY (2004)
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
JB Dixon et al.
HEPATOLOGY (2004)
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation
S Radaeva et al.
HEPATOLOGY (2004)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development
H Yoshiji et al.
HEPATOLOGY RESEARCH (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells:: evidence for matrix-dependent deactivation of stellate cells
MDA Gaça et al.
MATRIX BIOLOGY (2003)
Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype
B Schnabl et al.
HEPATOLOGY (2003)
Liver fibrosis - from bench to bedside
SL Friedman
JOURNAL OF HEPATOLOGY (2003)
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition - Implications for reversibility of liver fibrosis
FR Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B
YO Kweon et al.
JOURNAL OF HEPATOLOGY (2001)
Hepatic stellate cell behavior during resolution of liver injury
JP Iredale
SEMINARS IN LIVER DISEASE (2001)
History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells
A Geerts
SEMINARS IN LIVER DISEASE (2001)
Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts -: TGFβ signal transduction during transdifferentiation of hepatic stellate cells
S Dooley et al.
FEBS LETTERS (2001)
The role of Smad3 in mediating mouse hepatic stellate cell activation
B Schnabl et al.
HEPATOLOGY (2001)
Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites
R Abe et al.
JOURNAL OF IMMUNOLOGY (2001)
Genetic programs of epithelial cell plasticity directed by transforming growth factor-β
J Zavadil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors
R Issa et al.
GUT (2001)
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
P Hammel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
New aspects of hepatic fibrosis
DA Brenner et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
